A Case for Local Pharmaceutical Manufacturing in Africa in Light of the COVID-19 Pandemic

First page of paper
Year Published
Resource Type

This paper discusses the issue of scaling up the local pharmaceutical production in Africa as an opportunity, as well as a necessity, to tackle local epidemics of malaria, tuberculosis and HIV, as well as non-communicable diseases whose control could be undermined by the scale of the COVID-19 outbreak. Also available on the Pamela Steele Associates Ltd website.